Results 101 to 110 of about 5,806 (112)

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis

The Cochrane Library, 2014
Suetonia C Palmer, Jonathan C Craig, David W Johnson   +2 more
exaly  

Which Lipids Should Be Analyzed for Diagnostic Workup and Follow-up of Patients with Hyperlipidemias?

Current Cardiology Reports, 2018
Michel R Langlois, Børge G Nordestgaard
exaly  

Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus

The Cochrane Library, 2009
Victor M Montori, Sean F Dinneen
exaly  

Hyperlipidemia in Stroke Pathobiology and Therapy: Insights and Perspectives

Frontiers in Physiology, 2018
Ayman Elali
exaly  

HMG CoA reductase inhibitors (statins) for dialysis patients

The Cochrane Library, 2014
Suetonia C Palmer, Jonathan C Craig, David W Johnson   +2 more
exaly  

Evaluation of Lipid Peroxidation and Oxidative DNA Damage in Patients With Periodontitis and Hyperlipidemia

Journal of Periodontology, 2015
Zlem Fentoğlu, Justyna Ocha, Kamila Matyka   +2 more
exaly  

Obesity and Hyperlipidemia Modulate Alveolar Bone Loss in Wistar Rats

Journal of Periodontology, 2016
Juliano Cavagni, Isabel Cristina De Macedo, Andressa De Souza   +2 more
exaly  

Scutellarin Prevents Nonalcoholic Fatty Liver Disease (NAFLD) and Hyperlipidemia via PI3K/AKT-Dependent Activation of Nuclear Factor (Erythroid-Derived 2)-Like 2 (Nrf2) in Rats

Medical Science Monitor, 2017
Sean M Davidson
exaly  

A silent mutation of Niemann-Pick C1-like 1 and apolipoprotein E4 modulate cholesterol absorption in primary hyperlipidemias

Journal of Clinical Lipidology, 2013
Graziana Lupattelli, Livia Pisciotta, Stefano Bertolini   +2 more
exaly  

Atorvastatin for lowering lipids

The Cochrane Library, 2017
exaly